|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,133 INR | +3.26% |
|
+14.12% | +12.40% |
| Apr. 25 | GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology | RE |
| Mar. 22 | GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities | CI |
GlaxoSmithKline Pharmaceuticals Limited announced that Mr. Abhinav Kashyap - Pharma Technology Lead, has tendered his resignation effective from the close of business hours on 31st December 2023 to pursue other opportunities outside of the Company. As a result, he will also cease to be a Senior Management Personnel of the Company. The Company places on record appreciation for his contributions during his tenure with the Company.
The copy of his resignation email is enclosed herewith.
| 1st Jan change | Capi. | |
|---|---|---|
| +12.40% | 4.33B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED 
